Literature DB >> 15507668

Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Gunhild Trøen1, Vigdis Nygaard, Tor-Kristian Jenssen, Ida Münster Ikonomou, Anne Tierens, Estella Matutes, Alicja Gruszka-Westwood, Daniel Catovsky, Ola Myklebost, Grete Lauritzsen, Eivind Hovig, Jan Delabie.   

Abstract

Splenic marginal zone lymphoma (SMZL) is a lymphoma type of putative marginal zone B-cell origin. No specific genetic alterations have yet been demonstrated in SMZL. Clinically, SMZL is a low-grade B-cell non-Hodgkin lymphoma. However, the presence of p53 mutation, 7q22-7q32 deletion or the absence of somatic hypermutations of immunoglobulin genes has been correlated with a worse prognosis. In this study, we analyzed genome-wide gene expression of 24 cases of SMZL using the microarray technique. The AP-1 transcription factors c-jun, junD, junB, and c-fos as well as Notch2 were found to be specifically up-regulated. These data were confirmed by real-time PCR and immunohistochemical staining of tissue sections. The absence of concordant high expression of the MAP kinases, the signaling cascade leading to AP-1 up-regulation, suggests autoregulation of the AP-1 transcription factors and an important role in SMZL oncogenesis. High expression of Notch2, a transcription factor that induces marginal zone B-cell differentiation, is highly suggestive for a marginal zone B-cell origin of SMZL. In addition, SMZL with the 7q deletion showed high expression of TGF-beta1 and low expression of the DNA helicase XPB, a crucial part of the nucleotide excision repair complex, possibly explaining the more aggressive clinical course of those cases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15507668      PMCID: PMC1867488          DOI: 10.1016/S1525-1578(10)60525-9

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  37 in total

1.  Translocation t(2;7)(p12;q21-22) with dysregulation of the CDK6 gene mapping to 7q21-22 in a non-Hodgkin's lymphoma with leukemia.

Authors:  Vasantha Brito-Babapulle; Alicja M Gruszka-Westwood; Georgina Platt; Claus L Andersen; Manal O Elnenaei; Estella Matutes; Andrew C Wotherspoon; Simon G Weston-Smith; Daniel Catovsky
Journal:  Haematologica       Date:  2002-04       Impact factor: 9.941

Review 2.  Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis.

Authors:  E Piek; A B Roberts
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

Review 3.  Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.

Authors:  D Catovsky; E Matutes
Journal:  Semin Hematol       Date:  1999-04       Impact factor: 3.851

Review 4.  Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis.

Authors:  H van Dam; M Castellazzi
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 5.  Jun, the oncoprotein.

Authors:  P K Vogt
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

Review 6.  AP-1 in cell proliferation and survival.

Authors:  E Shaulian; M Karin
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

7.  Repression of activator protein-1-mediated transcriptional activation by the Notch-1 intracellular domain.

Authors:  Jianlin Chu; Shawn Jeffries; Jason E Norton; Anthony J Capobianco; Emery H Bresnick
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

8.  Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

Authors:  L Bakiri; D Lallemand; E Bossy-Wetzel; M Yaniv
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

9.  Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies.

Authors:  T Sonoki; L Harder; D E Horsman; L Karran; I Taniguchi; T G Willis; S Gesk; D Steinemann; E Zucca; B Schlegelberger; F Solé; A J Mungall; R D Gascoyne; R Siebert; M J Dyer
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

10.  Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

Authors:  Patricia Algara; Marisol S Mateo; Margarita Sanchez-Beato; Manuela Mollejo; Immaculada C Navas; Lourdes Romero; Francesc Solé; Marta Salido; Lourdes Florensa; Pedro Martínez; Elias Campo; Miguel A Piris
Journal:  Blood       Date:  2002-02-15       Impact factor: 22.113

View more
  17 in total

1.  Jun-regulated genes promote interaction of diffuse large B-cell lymphoma with the microenvironment.

Authors:  Marzenna Blonska; Yifan Zhu; Hubert H Chuang; M James You; Kranthi Kunkalla; Francisco Vega; Xin Lin
Journal:  Blood       Date:  2014-12-22       Impact factor: 22.113

Review 2.  Expression patterns of the activator protein-1 (AP-1) family members in lymphoid neoplasms.

Authors:  Alexandra Papoudou-Bai; Eleftheria Hatzimichael; Alexandra Barbouti; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2016-09-06       Impact factor: 3.984

3.  DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.

Authors:  Alberto J Arribas; Andrea Rinaldi; Afua A Mensah; Ivo Kwee; Luciano Cascione; Eloy F Robles; Jose A Martinez-Climent; David Oscier; Luca Arcaini; Luca Baldini; Roberto Marasca; Catherine Thieblemont; Josette Briere; Francesco Forconi; Alberto Zamò; Massimiliano Bonifacio; Manuela Mollejo; Fabio Facchetti; Stephan Dirnhofer; Maurilio Ponzoni; Govind Bhagat; Miguel A Piris; Gianluca Gaidano; Emanuele Zucca; Davide Rossi; Francesco Bertoni
Journal:  Blood       Date:  2015-01-22       Impact factor: 22.113

4.  YAP-TEAD signaling promotes basal cell carcinoma development via a c-JUN/AP1 axis.

Authors:  Dejan Maglic; Karin Schlegelmilch; Antonella Fm Dost; Riccardo Panero; Michael T Dill; Raffaele A Calogero; Fernando D Camargo
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

5.  Interleukin-1beta contributes via nitric oxide to the upregulation and functional activity of the zinc transporter Zip14 (Slc39a14) in murine hepatocytes.

Authors:  Louis A Lichten; Juan P Liuzzi; Robert J Cousins
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-01-29       Impact factor: 4.052

6.  Structure and promoter characterization of aldo-keto reductase family 1 B10 gene.

Authors:  Ziwen Liu; Linlin Zhong; Paulette A Krishack; Sarah Robbins; Julia X Cao; Yupei Zhao; Stephen Chung; Deliang Cao
Journal:  Gene       Date:  2009-02-21       Impact factor: 3.688

Review 7.  CARMA1-mediated NF-kappaB and JNK activation in lymphocytes.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  Multiple facets of junD gene expression are atypical among AP-1 family members.

Authors:  J M Hernandez; D H Floyd; K N Weilbaecher; P L Green; K Boris-Lawrie
Journal:  Oncogene       Date:  2008-04-21       Impact factor: 9.867

9.  Aldehyde dehydrogenase-1a1 induces oncogene suppressor genes in B cell populations.

Authors:  R Yasmeen; J M Meyers; C E Alvarez; J L Thomas; A Bonnegarde-Bernard; H Alder; T L Papenfuss; D M Benson; P N Boyaka; O Ziouzenkova
Journal:  Biochim Biophys Acta       Date:  2013-09-27

10.  JunD protects the liver from ischemia/reperfusion injury by dampening AP-1 transcriptional activation.

Authors:  Jennifer J Marden; Yulong Zhang; Fredrick D Oakley; Weihong Zhou; Meihui Luo; Hong Peng Jia; Paul B McCray; Moshe Yaniv; Jonathan B Weitzman; John F Engelhardt
Journal:  J Biol Chem       Date:  2008-01-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.